Erste Taxan-basierte Anthrazyklin-freie Chemotherapie in Kombination ...
Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer Herceptin(R) Helps Eradicate HER2-Positive Breast
chemie.pr-rss.com
30.05.2008 08:00:06
Roche Pharmaceuticals: Basel, Switzerland (ots/PRNewswire) - New data from a Phase II trial presented at the American Society of Clinical Oncology (ASCO) 2008 meeting showed that half of the patients with advanced, HER2-positive metastatic breast cancer whose disease had progressed during a Herceptin-containing regimen benefited from a combination of Herceptin and pertuzumab.(1) Pertuzumab inhibits the pairing of HER2 with other HER receptors, a key mechanism of ...
Lesen Sie hier weiter... |
Drucken |
PDF
Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer Herceptin(R) Helps Eradicate HER2-Positive Breast
Herceptin(R) Helps Eradicate HER2-Positive Breast Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer
Auf dieser Seite finden Sie Neuigkeiten zum Thema: Aktuelle Wirtschaftsnews, Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive
New Report Shows That Despite Poor Survival Rates Pertuzumab With Herceptin(R) Shows Impressive Results in Women With Advanced HER2-Positive Breast Cancer
No.1025, Poster No.6.E450b pertuzumab Results of a phase II trial of Tuesday Herceptin delivers high cure rates for women with HER2 positive early breast